OVERVIEW
This program will discuss the latest developments and best practices in the diagnosis and management of adult attention deficit/hyperactivity disorder (ADHD). It will incorporate current challenges and managing patients in the era of availability of multiple therapeutic options (stimulants and nonstimulants).
TARGET AUDIENCE
This activity is intended for psychiatrists, nurse practitioners within psychiatry, physician assistants within psychiatry, pediatricians, primary care physicians, pharmacists, nurses, and other clinicians who treat adult patients with attention deficit/hyperactivity disorder (ADHD).
GOAL STATEMENT
The goal of this activity is for learners to be better able to assess and manage ADHD in adult patients with special considerations for tailoring therapy, managing comorbidities, and mitigating risk of stimulant misuse and diversion.
LEARNING OBJECTIVES
Upon completion of this activity, participants will: Have greater competence related to[list][item]Assessing ADHD symptoms with evidence-based strategies[item]Mitigating stimulant misuse in adult patients with ADHD[item]Tailoring medication selection based on patient-specific factors for adult patients with ADHD[/list]
ACCREDITATION STATEMENT
[JALOGO][MEDSCAPE] In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
[bold]For Physicians[/bold] Medscape, LLC designates this live activity for a maximum of 1.0 [bold][italic]AMA PRA Category 1 Credits[/bold][/italic]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]For Nurses[/bold] Awarded 1.0 contact hour(s) of nursing continuing professional development for RNs and APNs. [bold]For Pharmacists[/bold] Medscape designates this continuing education activity for 1.0 contact hour(s) (0.100 CEUs) (Universal Activity Number: A0007105-0000-24-002-L01-P)
Renaissance Orlando at SeaWorld
6677 Sea Harbor Drive Plenary Room Peninsula 5-7
Orlando, Florida, 32821
United States
THIS SYMPOSIUM IS NOT SPONSORED, ENDORSED OR ACCREDITED BY THE AMERICAN PROFESSIONAL SOCIETY OF ADHD & RELATED DISORDERS.
Supported by an independent educational grant from [bold]Supernus Pharmaceuticals, Inc[/bold].